LIMK2 and neuroblastoma: In summary, this study shows that high LIMK2 levels correlate with resistance to a wide range of chemotherapeutic drugs through different mechanisms of action and that LIMK2 down-regulation increases the sensitivity of neuroblastoma cells to these drugs.